Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of brivaracetam in epilepsy
NCT01339559Phase 3Completed
- Sponsor
- UCB
- Start
- May 2011
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by UCB. Started May 2011; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01339559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339559.